Funded Grants

The Douglas-Bell Canada Brain Bank (DBCBB) houses and manages over 3,000 brains, as well as a large relational database containing demographic, clinical and developmental histories from the donors.

The traditional target-based drug development strategy (in vitro screening) has had poor success in developing new drugs.

Dr. De Koninck studies the persistent changes in spinal cord function that occur after nervous system injury that lead to chronic pain.

One of the frontiers in neuroscience is to understand the molecular dynamics of the brain functions.

Studies of genetic disorders are limited because of the lack of appropriate tissue samples from patients.

The Regeneration Unit in Neurobiology (RUN) Core facility is a purpose-built centre specializing in state of the art microscopic imaging of cells and tissue, as well as sophisticated behavioural analysis of laboratory rodents.

The Integrated Neurostimulation Platform for Neuropsychiatric Research offers the capacity to perform interleaved TMS/fMRI, a complex and demanding technique used to study brain function in neuropsychiatric disorders.

The neonatal brain is exquisitely vulnerable to the biological consequences of prematurity, birth asphyxia and congenital heart defects.

Neurological diseases including neurodegenerative, neurodevelopmental, and psychiatric disorders are collectively one of the leading causes of disability to the Canadian population.

Epilepsy is a common neurological condition that affects 1-2% of the population.